{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:43:58Z","timestamp":1786121038190,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04870-x","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:53:32Z","timestamp":1780527212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early warning value of serum TFF3 combined with pepsinogen ratio for monitoring the progression of gastric precancerous lesions: a retrospective study"],"prefix":"10.1186","volume":"26","author":[{"given":"Tao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"issue":"3","key":"4870_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"4870_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000002353","author":"S Wang","year":"2026","unstructured":"Wang S, Lv J, Wang L, Lin X, Wu H, Cao X. Gastric Cancer in China, 1990 to 2023: Trends, Modifiable Risks, and Prevention Priorities. J Clin Gastroenterol. 2026. https:\/\/doi.org\/10.1097\/MCG.0000000000002353.","journal-title":"J Clin Gastroenterol"},{"issue":"49","key":"4870_CR3","doi-asserted-by":"publisher","first-page":"e36439","DOI":"10.1097\/md.0000000000036439","volume":"102","author":"Y Chen","year":"2023","unstructured":"Chen Y, He L, Zheng X. Characteristics of multiple early gastric cancer and gastric high-grade intraepithelial neoplasia. Med (Baltim). 2023;102(49):e36439. https:\/\/doi.org\/10.1097\/md.0000000000036439.","journal-title":"Med (Baltim)"},{"issue":"7","key":"4870_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.17235\/reed.2022.9007\/2022","volume":"115","author":"Y Xing","year":"2023","unstructured":"Xing Y, Ma Y, Qiao Z. High-grade intraepithelial neoplasia of the cervical esophagus arising from a tiny ectopic gastric mucosa. Rev Esp Enferm Dig. 2023;115(7):389\u201390. https:\/\/doi.org\/10.17235\/reed.2022.9007\/2022.","journal-title":"Rev Esp Enferm Dig"},{"issue":"8","key":"4870_CR5","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.pan.2020.09.020","volume":"20","author":"J Nakahodo","year":"2020","unstructured":"Nakahodo J, Kikuyama M, Nojiri S, Chiba K, Yoshimoto K, Kamisawa T, et al. Focal parenchymal atrophy of pancreas: An important sign of underlying high-grade pancreatic intraepithelial neoplasia without invasive carcinoma, i.e., carcinoma in situ. Pancreatology. 2020;20(8):1689\u201397. https:\/\/doi.org\/10.1016\/j.pan.2020.09.020.","journal-title":"Pancreatology"},{"issue":"2","key":"4870_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3904\/kjim.2016.021","volume":"31","author":"JK Sung","year":"2016","unstructured":"Sung JK. Diagnosis and management of gastric dysplasia. Korean J Intern Med. 2016;31(2):201\u20139. https:\/\/doi.org\/10.3904\/kjim.2016.021.","journal-title":"Korean J Intern Med"},{"issue":"4","key":"4870_CR7","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1177\/03008916211014961","volume":"108","author":"D Trivanovic","year":"2022","unstructured":"Trivanovic D, Plestina S, Honovic L, Dobrila-Dintinjana R, Vlasic Tanaskovic J, Vrbanec D. Gastric cancer detection using the serum pepsinogen test method. Tumori. 2022;108(4):386\u201391. https:\/\/doi.org\/10.1177\/03008916211014961.","journal-title":"Tumori"},{"issue":"7","key":"4870_CR8","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1158\/1055-9965.Epi-22-0372","volume":"31","author":"MJ Zhou","year":"2022","unstructured":"Zhou MJ, Huang RJ. Catching Up with the World: Pepsinogen Screening for Gastric Cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2022;31(7):1257\u20138. https:\/\/doi.org\/10.1158\/1055-9965.Epi-22-0372.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"4870_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/labmed\/lmab035","volume":"53","author":"XL Han","year":"2022","unstructured":"Han XL, Yi CL, Ma JD, He Y, Wu LM, Wang YF, et al. Clinical value of pepsinogen in the screening, prevention, and diagnosis of gastric cancer. Lab Med. 2022;53(1):71\u20137. https:\/\/doi.org\/10.1093\/labmed\/lmab035.","journal-title":"Lab Med"},{"issue":"1","key":"4870_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000441742","volume":"93","author":"Y Yamaguchi","year":"2016","unstructured":"Yamaguchi Y, Nagata Y, Hiratsuka R, Kawase Y, Tominaga T, Takeuchi S, et al. Gastric cancer screening by combined assay for serum anti-helicobacter pylori IgG antibody and serum pepsinogen levels\u2013the ABC method. Digestion. 2016;93(1):13\u20138. https:\/\/doi.org\/10.1159\/000441742.","journal-title":"Digestion"},{"issue":"9","key":"4870_CR11","first-page":"141","volume":"30","author":"H Chen","year":"2024","unstructured":"Chen H, Xu H. Effect of gastrin G-17 combined with pepsinogen PGI and PGII on the early screening of gastric cancer in the department of gastroenterology. Altern Ther Health Med. 2024;30(9):141\u20135.","journal-title":"Altern Ther Health Med"},{"issue":"2","key":"4870_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/1354750x.2020.1871411","volume":"26","author":"CX Zhang","year":"2021","unstructured":"Zhang CX, Wu CT, Xiao L, Tang SH. The diagnostic and clinicopathological value of trefoil factor 3 in patients with gastric cancer: a systematic review and meta-analysis. Biomarkers. 2021;26(2):95\u2013102. https:\/\/doi.org\/10.1080\/1354750x.2020.1871411.","journal-title":"Biomarkers"},{"issue":"12","key":"4870_CR13","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1007\/s00268-018-4737-0","volume":"42","author":"Y Taniguchi","year":"2018","unstructured":"Taniguchi Y, Kurokawa Y, Takahashi T, Mikami J, Miyazaki Y, Tanaka K, et al. Prognostic value of trefoil factor 3 expression in patients with gastric cancer. World J Surg. 2018;42(12):3997\u20134004. https:\/\/doi.org\/10.1007\/s00268-018-4737-0.","journal-title":"World J Surg"},{"issue":"6","key":"4870_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.gastrohep.2022.04.004","volume":"46","author":"G Latorre","year":"2023","unstructured":"Latorre G, Pizarro M, Ford JS, G\u00e1ndara V, Mu\u00f1oz G, Araya JC, et al. Evaluation of trefoil factor 3 as a non-invasive biomarker of gastric intestinal metaplasia and gastric cancer in a high-risk population. Gastroenterol Hepatol. 2023;46(6):411\u20138. https:\/\/doi.org\/10.1016\/j.gastrohep.2022.04.004.","journal-title":"Gastroenterol Hepatol"},{"issue":"6","key":"4870_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/1354750x.2024.2400927","volume":"29","author":"J Zhao","year":"2024","unstructured":"Zhao J, Tian W, Zhang X, Dong S, Shen Y, Gao X, et al. The diagnostic value of serum trefoil factor 3 and pepsinogen combination in chronic atrophic gastritis: a retrospective study based on a gastric cancer screening cohort in the community population. Biomarkers. 2024;29(6):384\u201392. https:\/\/doi.org\/10.1080\/1354750x.2024.2400927.","journal-title":"Biomarkers"},{"issue":"7","key":"4870_CR16","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.31557\/apjcp.2020.21.7.2149","volume":"21","author":"RA Ramadan","year":"2020","unstructured":"Ramadan RA, Zaki MA, Ooda SA, Abo Khalifa HM, Ragab WS. Comparison of serum trefoil factor-3 to endoscopy in diagnosing helicobacter pylori associated gastric ulcer. Asian Pac J Cancer Prev. 2020;21(7):2149\u201353. https:\/\/doi.org\/10.31557\/apjcp.2020.21.7.2149.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"4870_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.21147\/j.issn.1000-9604.2019.05.01","volume":"31","author":"National Health Commission Of The People\u2019s Republic Of C","year":"2019","unstructured":"National Health Commission Of The People\u2019s Republic Of C. Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version). Chin J Cancer Res. 2019;31(5):707\u201337. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2019.05.01.","journal-title":"Chin J Cancer Res"},{"key":"4870_CR18","doi-asserted-by":"publisher","unstructured":"Villarroel-Esp\u00edndola F, Jaupi L, Reyes J, Barrientos C, Podest\u00e1 C, Selman C, et al. Spatial Study of TLR4, TLR5 and TLR9 in Gastric Premalignant Lesions Before and After Helicobacter pylori Eradication. Int J Mol Sci. 2025;26(9). https:\/\/doi.org\/10.3390\/ijms26094059.","DOI":"10.3390\/ijms26094059"},{"issue":"1","key":"4870_CR19","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.1038\/s41598-017-05129-y","volume":"7","author":"Y Ishibashi","year":"2017","unstructured":"Ishibashi Y, Ohtsu H, Ikemura M, Kikuchi Y, Niwa T, Nishioka K, et al. Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer. Sci Rep. 2017;7(1):4846. https:\/\/doi.org\/10.1038\/s41598-017-05129-y.","journal-title":"Sci Rep"},{"key":"4870_CR20","doi-asserted-by":"publisher","unstructured":"Aikou S, Ohmoto Y, Gunji T, Matsuhashi N, Ohtsu H, Miura H et al. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. Gastroenterology. 2011; 141(3): 837\u2013845 e831-837. https:\/\/doi.org\/10.1053\/j.gastro.2011.05.040","DOI":"10.1053\/j.gastro.2011.05.040"},{"key":"4870_CR21","doi-asserted-by":"publisher","first-page":"110470","DOI":"10.1016\/j.cellsig.2022.110470","volume":"100","author":"Z Lin","year":"2022","unstructured":"Lin Z, Wan X, Zhang T, Huo H, Zhang X, Li K, et al. Trefoil factor 3: New highlights in chronic kidney disease research. Cell Signal. 2022;100:110470. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110470.","journal-title":"Cell Signal"},{"issue":"4","key":"4870_CR22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3892\/ijo.2019.4854","volume":"55","author":"A Yusufu","year":"2019","unstructured":"Yusufu A, Shayimu P, Tuerdi R, Fang C, Wang F, Wang H. TFF3 and TFF1 expression levels are elevated in colorectal cancer and promote the malignant behavior of colon cancer by activating the EMT process. Int J Oncol. 2019;55(4):789\u2013804. https:\/\/doi.org\/10.3892\/ijo.2019.4854.","journal-title":"Int J Oncol"},{"issue":"3","key":"4870_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41419-022-04700-4","volume":"13","author":"F Cheng","year":"2022","unstructured":"Cheng F, Wang X, Chiou YS, He C, Guo H, Tan YQ, et al. Trefoil factor 3 promotes pancreatic carcinoma progression via WNT pathway activation mediated by enhanced WNT ligand expression. Cell Death Dis. 2022;13(3):265. https:\/\/doi.org\/10.1038\/s41419-022-04700-4.","journal-title":"Cell Death Dis"},{"key":"4870_CR24","doi-asserted-by":"publisher","unstructured":"Bazin T, Nozeret K, Julie C, Lamarque D, Touati E. Protein Biomarkers of Gastric Preneoplasia and Cancer Lesions in Blood: A Comprehensive Review. Cancers (Basel). 2024;16(17). https:\/\/doi.org\/10.3390\/cancers16173019.","DOI":"10.3390\/cancers16173019"},{"issue":"6","key":"4870_CR25","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s00535-011-0396-8","volume":"46","author":"M Kaise","year":"2011","unstructured":"Kaise M, Miwa J, Tashiro J, Ohmoto Y, Morimoto S, Kato M, et al. The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk. J Gastroenterol. 2011;46(6):736\u201345. https:\/\/doi.org\/10.1007\/s00535-011-0396-8.","journal-title":"J Gastroenterol"},{"key":"4870_CR26","doi-asserted-by":"publisher","first-page":"111587","DOI":"10.1016\/j.intimp.2024.111587","volume":"128","author":"RN El Mahdy","year":"2024","unstructured":"El Mahdy RN, Nader MA, Helal MG, Abu-Risha SE, Abdelmageed ME. Tiron ameliorates acetic acid-induced colitis in rats: Role of TGF-\u03b2\/EGFR\/PI3K\/NF-\u03baB signaling pathway. Int Immunopharmacol. 2024;128:111587. https:\/\/doi.org\/10.1016\/j.intimp.2024.111587.","journal-title":"Int Immunopharmacol"},{"issue":"21","key":"4870_CR27","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.19540\/j.cnki.cjcmm.20240729.501","volume":"49","author":"SL Li","year":"2024","unstructured":"Li SL, Lu GG, Jin GW, Yin PD, Gong MS, Li H, et al. [Research progress of traditional Chinese medicine in treatment of benign prostatic hyperplasia]. Zhongguo Zhong Yao Za Zhi. 2024;49(21):5817\u201328. https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20240729.501.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"1","key":"4870_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12672-024-01091-0","volume":"15","author":"J Zhang","year":"2024","unstructured":"Zhang J, Liu J, Dong L, Wang X, Mao X, Mao Y, et al. PG I and PG II show unique value in diagnosing postoperative biochemical recurrence in patients with gastric cancer after total gastrectomy. Discov Oncol. 2024;15(1):231. https:\/\/doi.org\/10.1007\/s12672-024-01091-0.","journal-title":"Discov Oncol"},{"issue":"25","key":"4870_CR29","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.3748\/wjg.v26.i25.3673","volume":"26","author":"L Yuan","year":"2020","unstructured":"Yuan L, Zhao JB, Zhou YL, Qi YB, Guo QY, Zhang HH, et al. Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area. World J Gastroenterol. 2020;26(25):3673\u201385. https:\/\/doi.org\/10.3748\/wjg.v26.i25.3673.","journal-title":"World J Gastroenterol"},{"key":"4870_CR30","doi-asserted-by":"publisher","unstructured":"Lee HS, Jeon SW, Nomura S, Seto Y, Kwon YH, Nam SY, et al. Screening biomarker as an alternative to endoscopy for the detection of early gastric cancer: the combination of serum trefoil factor family 3 and pepsinogen. Gastroenterol Res Pract. 2018;20181024074. https:\/\/doi.org\/10.1155\/2018\/1024074.","DOI":"10.1155\/2018\/1024074"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04870-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04870-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04870-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T02:32:34Z","timestamp":1786069954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04870-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4870"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04870-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study is a retrospective-analyses based on the electronic medical records from Wusong Central Hospital and Wusong Branch of Zhongshan Hospital, which was conducted in accordance with the principles of the Declaration of Helsinki. The access of patients\u2019 medical records was approved by the Ethic committee of Wusong Central Hospital (Approval No: WSH-2023-012) and the Ethic committee of Wusong Branch of Zhongshan Hospital (Approval No: ZSWSH-2023-008). Due to the retrospective nature of this study and that no identifiable personal information was involved, the requirement for informed consent to participate was waived by the above two Ethics Committees.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"492"}}